Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome P450RAI

Details for Australian Patent Application No. 2001286478 (hide)

Owner Allergan, Inc.

Inventors Chandraratna, Roshantha A; Johnson, Alan T; Huang, Dehua; Vasudevan, Jayasree; Wang, Li-Ming

Agent Davies Collison Cave

Pub. Number AU-B-2001286478

PCT Pub. Number WO02/26727

Priority 09672751 28.09.00 US

Filing date 14 August 2001

Wipo publication date 8 April 2002

Acceptance publication date 1 November 2007

International Classifications

C07D 233/60 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/192 (2006.01)

A61K 31/195 (2006.01)

A61K 31/196 (2006.01)

A61K 31/216 (2006.01)

A61K 31/232 (2006.01)

A61K 31/24 (2006.01)

A61K 31/353 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61K 31/4174 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4747 (2006.01) - spiro-condensed

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/06 (2006.01) Drugs for disorders of the endocrine system

A61P 5/10 (2006.01) Drugs for disorders of the endocrine system

A61P 5/38 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 Drugs for disorders of the cardiovascular system

Event Publications

1 November 2007 Application Accepted

  Published as AU-B-2001286478

28 February 2008 Standard Patent Sealed

24 April 2008 Licence Registered

  Allergan, Inc. ( Vitae Pharmaceuticals, Inc. )

12 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001286479-FACILITATING ELECTRONIC COMMERCE MARKETPLACES BY AUTOMATICALLY GENERATING FILES FROM A STRUCTURAL ONTOLOGY SPECIFICATION

2001286477